中华急诊医学杂志
中華急診醫學雜誌
중화급진의학잡지
CHINESE JOURNAL OF EMERGENCY MEDICINE
2009年
9期
964-967
,共4页
任宏生%蒋进皎%王春亭%张继承%孟玫%于杰滨%郄国强%楚玉峰%靳长俊
任宏生%蔣進皎%王春亭%張繼承%孟玫%于傑濱%郄國彊%楚玉峰%靳長俊
임굉생%장진교%왕춘정%장계승%맹매%우걸빈%극국강%초옥봉%근장준
质子泵抑制剂%奥美拉唑%重症患者%应激性消化道黏膜损伤%疗效
質子泵抑製劑%奧美拉唑%重癥患者%應激性消化道黏膜損傷%療效
질자빙억제제%오미랍서%중증환자%응격성소화도점막손상%료효
Proton pump inhibitors%Omeprazole%Intensive care patients%Stress-related mucosal injury%Therapy effect
目的 探讨持续静脉注射大剂量奥美拉唑防治重症患者并发应激性消化道黏膜损伤的疗效.方法 选取2006年8月至2008年10月山东大学附属省立医院的重症监护室的并发应激性消化道黏膜损伤的98例危重症患者,随机分为大剂量奥美拉唑组(A组)和对照组(B组).A组首剂5min内静脉推注80 mg奥美拉唑,后8.0 mg/h静脉泵入,72 h;B组40mg/h静脉滴注奥美拉唑,1次/8 h,1次/72 h.两组患者均定期用pH试纸枪测条监测胃液pH值,观察胃肠减压器中是否有咖啡色或红色引流物.全自动血细胞分析仪监测血红蛋白、全自动生化分析仪测定血尿素氮、动脉血气分析仪测定动脉血碱剩余.两组之间均数比较用t-test,发生率用χ2检验.结果 治疗4 h后,A组胃液pH值较B组升高[(6.63±0.62)vs.(3.14±0.26),P<0.01],治疗8 h,16 h及24 h,胃液pH值也均高于B组(P<0.05或P<0.01).治疗后8 h,24 h,A组血红蛋白高于B组、血尿素氮低于B组、动脉血碱剩余负值低于B组(P<0.05或P<0.01).A组的胃肠道止血总有效率高于B组(95.35%vs.78.19%,P<0.05).结论 重症患者并发应激性消化道黏膜损伤,大剂量奥美拉唑治疗效果优于常规给药.
目的 探討持續靜脈註射大劑量奧美拉唑防治重癥患者併髮應激性消化道黏膜損傷的療效.方法 選取2006年8月至2008年10月山東大學附屬省立醫院的重癥鑑護室的併髮應激性消化道黏膜損傷的98例危重癥患者,隨機分為大劑量奧美拉唑組(A組)和對照組(B組).A組首劑5min內靜脈推註80 mg奧美拉唑,後8.0 mg/h靜脈泵入,72 h;B組40mg/h靜脈滴註奧美拉唑,1次/8 h,1次/72 h.兩組患者均定期用pH試紙鎗測條鑑測胃液pH值,觀察胃腸減壓器中是否有咖啡色或紅色引流物.全自動血細胞分析儀鑑測血紅蛋白、全自動生化分析儀測定血尿素氮、動脈血氣分析儀測定動脈血堿剩餘.兩組之間均數比較用t-test,髮生率用χ2檢驗.結果 治療4 h後,A組胃液pH值較B組升高[(6.63±0.62)vs.(3.14±0.26),P<0.01],治療8 h,16 h及24 h,胃液pH值也均高于B組(P<0.05或P<0.01).治療後8 h,24 h,A組血紅蛋白高于B組、血尿素氮低于B組、動脈血堿剩餘負值低于B組(P<0.05或P<0.01).A組的胃腸道止血總有效率高于B組(95.35%vs.78.19%,P<0.05).結論 重癥患者併髮應激性消化道黏膜損傷,大劑量奧美拉唑治療效果優于常規給藥.
목적 탐토지속정맥주사대제량오미랍서방치중증환자병발응격성소화도점막손상적료효.방법 선취2006년8월지2008년10월산동대학부속성립의원적중증감호실적병발응격성소화도점막손상적98례위중증환자,수궤분위대제량오미랍서조(A조)화대조조(B조).A조수제5min내정맥추주80 mg오미랍서,후8.0 mg/h정맥빙입,72 h;B조40mg/h정맥적주오미랍서,1차/8 h,1차/72 h.량조환자균정기용pH시지창측조감측위액pH치,관찰위장감압기중시부유가배색혹홍색인류물.전자동혈세포분석의감측혈홍단백、전자동생화분석의측정혈뇨소담、동맥혈기분석의측정동맥혈감잉여.량조지간균수비교용t-test,발생솔용χ2검험.결과 치료4 h후,A조위액pH치교B조승고[(6.63±0.62)vs.(3.14±0.26),P<0.01],치료8 h,16 h급24 h,위액pH치야균고우B조(P<0.05혹P<0.01).치료후8 h,24 h,A조혈홍단백고우B조、혈뇨소담저우B조、동맥혈감잉여부치저우B조(P<0.05혹P<0.01).A조적위장도지혈총유효솔고우B조(95.35%vs.78.19%,P<0.05).결론 중증환자병발응격성소화도점막손상,대제량오미랍서치료효과우우상규급약.
Objective To study the therapeutic effects of omeprazoie in high-dose given by continuous intravenous infusion in the treatment of stress-related mucosal injury of G-I tract in intensive care patients.Method Totally 98 intensive care patients with stress-related mucosal injury(SRMI)were enrolled from August 2006 to October 2008 Department in Intensive Care Unit(ICU)of the Provincial Hospital Affiliated to Shandong University.All the patients were randomly divided into high-dose omeprazoie group(group A)and control group(group B).In group A,omeprazoie was administrated in loading dose of 80 mg Ⅰ.Ⅴ.in 5 minutes followed by maintenance dose of 8.0 mg/h intravenous infusion for 72 hours,while in group B,omeprazoie was given in dose of 40mg/8h intravenous infusion for 72 hours.The pH value of gastric juice was determined by German Roche pH test paper every 2 to 8 hours in the patients of both groups.The coffee like or red juice in the gastrointestine decompressor was observed.At the same time,hemoglobin(HB)was detected by Automatic blood cell analyzer Sysmex XE-2100,blood urea nitrogen(BUN)was determined by Automatic Analyzer Au5400,and buffer excess(BE)was checked by GEM Premie arterial blood gas analyzer in all patients.Data were expressed as mean ± standard deviation(x-± s)and the analysis of variance was done with SPSS 12.0 software.Comparison of mean value between two groups was conducted with t-test and the ratio was calculated by using chi-square test(X2 test).The change was considered as statistically significant if P value was less than 0.05.Results Four,eight,and 24 hours after treatment with omeprazole,the pH values in patients of group A were higher than those in patients of group B(four hous:6.63 ±0.62 vs.3.14 ±0.26,P<0.01;eight hours and 24 hours:P<0.05 or P<0.01).At 8 hours and 24 hours after treatment,the HB was higher,BUN and BE were lower in group A than those in group B(P<0.03 or P<0.01).The total rate of hemostasis of upper G-I tract bleeding in group A was higher than that in group B(95.35%vs.78.19%,P<0.05).Conclusions For treating the intensive care patients with SRMI,the continues intravenous infusion of omeprazole inhigh dose is superior to conventional dosage.